China’s domestic markets had 48 public listings during the first quarter of 2014, raising total capital of $5.8 billion, according to figures from Zero2IPO.
Last year China had no domestic listings due to a regulatory freeze as authorities reformed the listing process.
Both domestic and overseas IPOs of Chinese companies in Q1 totaled 63, putting total capital raised at $8.6 billion.
The US is preparing for a wave of China company IPOs. Alibaba, Weibo, JD.com and Chinese medical center operator iKang are among those in the pipeline this year. The lineup signals a resurgence in overseas listings from 2010, when high profile accounting scandals at some US-listed Chinese companies had tainted them all, sending valuations down and sparking a wave of private equity take-private deals.
RMB private equity fundraising involving institutional capital, excluding real estate and venture, was also up in Q1, according to Private Equity International’s Research & Analytics division.
A total of 6 billion RMB (€703 million; $966 million) was raised year-to-date compared to 2.5 billion RMB during the same period in 2013, and 2.13 billion RMB in Q1 2012.
Last year, RMB funds dropped by more than 60 percent to 11.3 billion RMB, PEI reported earlier.